These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

505 related articles for article (PubMed ID: 16912549)

  • 1. Assessment of inflammatory markers and endothelial function.
    Järvisalo MJ; Juonala M; Raitakari OT
    Curr Opin Clin Nutr Metab Care; 2006 Sep; 9(5):547-52. PubMed ID: 16912549
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Rheumatoid arthritis, inflammation, and atherosclerosis].
    Hürlimann D; Enseleit F; Ruschitzka F
    Herz; 2004 Dec; 29(8):760-8. PubMed ID: 15599672
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of inflammation in atherosclerosis associated with rheumatoid arthritis.
    Libby P
    Am J Med; 2008 Oct; 121(10 Suppl 1):S21-31. PubMed ID: 18926166
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endothelial function and atherosclerosis: circulatory markers with clinical usefulness.
    Ribeiro F; Alves AJ; Teixeira M; Ribeiro V; Duarte JA; Oliveira J
    Rev Port Cardiol; 2009 Oct; 28(10):1121-51. PubMed ID: 20058778
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endothelial dysfunction in obesity: etiological role in atherosclerosis.
    Meyers MR; Gokce N
    Curr Opin Endocrinol Diabetes Obes; 2007 Oct; 14(5):365-9. PubMed ID: 17940464
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardiovascular risk and rheumatoid arthritis: from mechanisms of atherosclerosis to therapeutic approach.
    Jurcuţ C; Jurcuţ R; Tănăsescu C
    Rom J Intern Med; 2004; 42(4):659-69. PubMed ID: 16366138
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum markers of vascular inflammation in dyslipemia.
    Francisco G; Hernández C; Simó R
    Clin Chim Acta; 2006 Jul; 369(1):1-16. PubMed ID: 16469304
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessment of endothelial function as a marker of cardiovascular risk in patients with rheumatoid arthritis.
    Khan F
    Int J Rheum Dis; 2010 Aug; 13(3):189-95. PubMed ID: 20704614
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inflammation and atherosclerosis.
    Steffens S; Mach F
    Herz; 2004 Dec; 29(8):741-8. PubMed ID: 15599670
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thiazolidinediones-improving endothelial function and potential long-term benefits on cardiovascular disease in subjects with type 2 diabetes.
    Dandona P; Ghanim H; Chaudhuri A; Mohanty P
    J Diabetes Complications; 2008; 22(1):62-75. PubMed ID: 18191079
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Atherosclerosis and rheumatoid arthritis].
    Löwenhoff T; Głuszko P
    Przegl Lek; 2005; 62(12):1506-9. PubMed ID: 16786783
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endothelial dysfunction in the pathogenesis of atherosclerosis.
    Poredos P
    Int Angiol; 2002 Jun; 21(2):109-16. PubMed ID: 12110769
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Linking inflammation and atherogenesis: Soluble markers identified for the detection of risk factors and for early risk assessment.
    Wu JT; Wu LL
    Clin Chim Acta; 2006 Apr; 366(1-2):74-80. PubMed ID: 16343470
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The current opinion on inflammatory, biochemistry and hemostatic markers and factors in atherosclerosis. Part I].
    Rajtar R; Kloch M; Bober M; Kolasińska-Kloch W
    Przegl Lek; 2006; 63(9):762-6. PubMed ID: 17479866
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [New non-lipidic biological markers of atherosclerosis].
    Beaudeux JL; Jacob N; Giral P; Foglietti MJ; Bruckert E
    Ann Med Interne (Paris); 2001 Apr; 152(3):169-79. PubMed ID: 11431576
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CXCL16 is a marker of inflammation, atherosclerosis, and acute coronary syndromes in humans.
    Lehrke M; Millington SC; Lefterova M; Cumaranatunge RG; Szapary P; Wilensky R; Rader DJ; Lazar MA; Reilly MP
    J Am Coll Cardiol; 2007 Jan; 49(4):442-9. PubMed ID: 17258089
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Review of the evidence for the clinical utility of lipoprotein-associated phospholipase A2 as a cardiovascular risk marker.
    Corson MA; Jones PH; Davidson MH
    Am J Cardiol; 2008 Jun; 101(12A):41F-50F. PubMed ID: 18549871
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Patients with primary antiphospholipid antibody syndrome and without associated vascular risk factors present a normal endothelial function.
    Gresele P; Migliacci R; Vedovati MC; Ruffatti A; Becattini C; Facco M; Guglielmini G; Boscaro E; Mezzasoma AM; Momi S; Pengo V
    Thromb Res; 2009; 123(3):444-51. PubMed ID: 18617225
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inflammation: a pivotal link between autoimmune diseases and atherosclerosis.
    Abou-Raya A; Abou-Raya S
    Autoimmun Rev; 2006 May; 5(5):331-7. PubMed ID: 16782558
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endothelial function and novel adhesion molecule CD44 in kidney allograft recipients.
    Malyszko J; Malyszko JS; Pawlak K; Mysliwiec M
    Transplant Proc; 2008 Dec; 40(10):3470-3. PubMed ID: 19100415
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.